Interpharm Holdings, Inc.
IPAH · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Revenue | $16 | $18 | $15 | $20 |
| % Growth | -8.5% | 15.2% | -22.8% | – |
| Cost of Goods Sold | $14 | $17 | $13 | $14 |
| Gross Profit | $2 | $1 | $2 | $6 |
| % Margin | 14% | 6.1% | 14.8% | 32% |
| R&D Expenses | $3 | $3 | $6 | $5 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $7 | $10 | $9 |
| Operating Income | -$4 | -$6 | -$7 | -$2 |
| % Margin | -24.3% | -34.7% | -47.9% | -11.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | -$0 |
| Pre-Tax Income | -$5 | -$7 | -$8 | -$3 |
| Tax Expense | $6 | $0 | $2 | -$1 |
| Net Income | -$11 | -$7 | -$10 | -$2 |
| % Margin | -67.2% | -38.9% | -63.2% | -9.3% |
| EPS | -0.21 | -0.1 | -0.153 | -0.04 |
| % Growth | -110% | 34.8% | -283.2% | – |
| EPS Diluted | -0.21 | -0.1 | -0.153 | -0.04 |
| Weighted Avg Shares Out | 67 | 66 | 65 | 65 |
| Weighted Avg Shares Out Dil | 67 | 66 | 65 | 65 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$3 | -$5 | -$6 | -$2 |
| % Margin | -18.3% | -29.5% | -42.2% | -8.4% |